AMGN
Amgen Inc.
Is AMGN Halal?
Medicines are generally permissible and beneficial, but March 2026 debt was 61.97% of assets, failing the examined total-assets methods.
What You Should Know
Amgen develops, manufactures and sells human therapeutics, an activity that generally supports preservation of health and life. Its current liquidity, receivables and disclosed-interest ratios pass the examined limits, but debt is above all three total-assets thresholds. Market-cap methods are not calculated without reproducible historical denominator data, and product-level screened revenue is not disclosed. The prior blanket porcine-material concern is replaced with a product-specific evidence requirement.
⚠️ Concerns
- •Debt was 61.97% of total assets
- •Product ingredients, excipients, cell lines and manufacturing inputs require product-specific evidence
- •Clinical trials, patient safety, animal research and pharmacovigilance
- •Pricing, access, patents, reimbursement and healthcare-provider relationships
- •Screened product, royalty and licensing revenue is not separately disclosed
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-12.
57,323 / 92,504
13,165 / 92,504
21,176 / 92,504
101 / 8,618
- Financial
- Fails
- Overall
- Fails
Debt is 61.97% of total assets, above the 33.333% limit. Liquidity is 14.23%, receivables plus cash is 22.89%, and disclosed interest income is 1.17%, all within their examined limits.
- Financial
- Fails
- Overall
- Fails
Debt is above the 33.33% total-assets limit even though the identifiable liquidity and receivables ratios are below their limits.
- Financial
- Fails
- Overall
- Fails
Debt is above 33% of total assets, and a screened business-revenue percentage is unavailable. This is a calculation against the SAC ratios, not an official SAC classification of a U.S.-listed security.
- Financial
- Not calculated
- Overall
- Not calculated
A properly licensed and reproducible 24- or 36-month issuer market-cap history is not yet stored, so these methods are not estimated from a current spot price.
Business-activity disclosure
Amgen develops, manufactures and sells human therapeutics. Medicines and biotechnology that preserve health and life are generally permissible and socially beneficial activities, subject to product-specific ingredients, manufacturing, research and commercial practices.
Limitation: The filing does not classify revenue by Sharia-screened ingredient, excipient, cell line, manufacturing input, research method, licensing arrangement or product use. No prohibited core segment is identified, but an exact prohibited-revenue percentage cannot be proven from the consolidated disclosure.
Purification
Disclosed interest income equals 1.17% of quarterly revenue, but screened operating revenue remains unavailable. The ratio is evidence for the income screen, not a complete fixed purification prescription.
Inputs, assumptions and primary sources
- Interest-bearing debt is the sum of 5,437 of current long-term debt and 51,886 of long-term debt.
- Cash and cash equivalents use the reported 12,038 balance. Money-market mutual funds classified within cash equivalents are not counted again as securities.
- Interest-bearing securities are 996 of U.S. Treasury bills plus 131 of other short-term interest-bearing securities, all maturing within one year.
- Receivables use the reported 9,138 net trade-receivables balance.
- Revenue and the disclosed 101 of interest income use the same three-month period ended March 31, 2026.
- Amgen reports product sales and other revenue but does not provide a Sharia-screened numerator for product ingredients, manufacturing inputs, licensing, royalties, or other potentially non-compliant activity.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →